Skip to main navigation Skip to search Skip to main content

Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

  • Vinod Pullarkat
  • , Keith W. Pratz
  • , Hartmut Döhner
  • , Christian Recher
  • , Michael J. Thirman
  • , Courtney D. DiNardo
  • , Pierre Fenaux
  • , Andre C. Schuh
  • , Andrew H. Wei
  • , Arnaud Pigneux
  • , Jun Ho Jang
  • , Gunnar Juliusson
  • , Yasushi Miyazaki
  • , Dominik Selleslag
  • , Martha L. Arellano
  • , Chenglong Liu
  • , Jean A. Ridgeway
  • , Jalaja Potluri
  • , Jovita Schuler
  • , Marina Konopleva
  • City of Hope National Med Center
  • University of Pennsylvania
  • Ulm University
  • CHU de Toulouse
  • The University of Chicago
  • Albert Einstein College of Medicine
  • Université Paris Cité
  • Princess Margaret Cancer Centre
  • Walter and Eliza Hall Institute of Medical Research
  • University Hospital of Bordeaux – Hôpital St. André
  • Lund University
  • Nagasaki University
  • General Hospital St. Jan
  • Emory University
  • AbbVie

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number49
JournalBlood Cancer Journal
Volume15
Issue number1
DOIs
StatePublished - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this